Divozilimab, CAS 2254061-60-2

Product Description: Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab can be used for multiple sclerosis research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]O V Boyko, et al. Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):87-95.

CAS Number: 2254061-60-2

Molecular Weight: N/A

Compound Purity: 99.63

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: CD20

• SKU: MEXHY-P99855-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99855-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated